{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/achilles-tendinopathy/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"bf28c805-c8fd-5214-92fd-164c8c8788a3","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field 1127a03a-a3bf-47f0-877a-f37ede34fcc1 --><h2>What is the prevalence?</h2><!-- end field 1127a03a-a3bf-47f0-877a-f37ede34fcc1 -->","summary":"","htmlStringContent":"<!-- begin item 845e7ca6-c96b-4ead-ba28-c96c432845e6 --><!-- begin field 57ae9e0f-f0f5-4783-9fcf-8d8ae11e2396 --><ul><li>Achilles tendon pathology is common in active people [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Maffulli, 2019</a>].  </li><li><strong>Achilles tendinopathy: </strong><ul><li>Has an increasing incidence, which may be due to increased sporting activity and longer and more intense training [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Ackermann, 2018a</a>]. It is estimated to affect more than 150,000 people in the UK every year [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Kearney, 2013</a>].<ul><li>A Dutch cross-sectional study in a general practice population found, for Achilles tendinopathy, a prevalence rate of 2.35 and incidence rate of 2.16 per 1000 person-years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Albers, 2016</a>].  </li><li>A registry-based study in a Danish general practice found a prevalence of 5.2 per 1000 registered patients and an incidence rate of 1.7 per 1000 registered patients for Achilles tendinopathy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Riel, 2019</a>].  </li></ul></li><li>Is more common in runners, especially middle-aged, middle-distance, and long-distance runners [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Ackermann, 2018a</a>].  </li><li>Occurs in sports other than running. The estimated prevalence in dancers is 9%, in gymnasts 5%, in tennis players 2%, and in football players less than 1% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Wilson, 2010</a>].  </li></ul></li><li><strong>Insertional Achilles tendinopathy</strong> is more common in older people, retired athletes, or less athletic, overweight people [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Maffulli, 2019</a>].  </li><li><strong>Achilles tendon rupture:</strong><ul><li>Is common — around 4500 people in the UK seek medical help for this injury each year [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Boyd, 2015</a>].  </li><li>Has an annual incidence of approximately 18 per 100,000 people [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Uquillas, 2015</a>].  </li><li>Has a mean age of 37–43.5 years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/achilles-tendinopathy/references/\">Uquillas, 2015</a>]. </li></ul></li></ul><!-- end field 57ae9e0f-f0f5-4783-9fcf-8d8ae11e2396 --><!-- end item 845e7ca6-c96b-4ead-ba28-c96c432845e6 -->","topic":{"id":"a4ec84b7-886a-5579-a133-17740dcc72c3","topicId":"544c0dd8-12b4-472f-8325-25f15b3092e3","topicName":"Achilles tendinopathy","slug":"achilles-tendinopathy","lastRevised":"Last revised in June 2020","chapters":[{"id":"342af048-69de-5cc6-83ef-2d9535909c69","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"f4364122-f06e-518b-b540-17c7f31d1e11","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b099b421-395c-5c3e-a52a-08a168943a2d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"43885ca6-3854-57e0-b673-d00e904a68d0","slug":"changes","fullItemName":"Changes"},{"id":"618c6e12-afee-5776-9b09-d249d2e5d4a6","slug":"update","fullItemName":"Update"}]},{"id":"cebb13f2-1c56-5eb8-bc8c-7826b141e1dc","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"ea10f3ef-0f07-5ca3-b9ba-c799e2c0ecae","slug":"goals","fullItemName":"Goals"},{"id":"c3f6243c-b2ef-5320-8fe9-974cc62e5088","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c166d91e-6f69-5a9c-80b7-83af1faa167b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7c802a6f-65e8-5050-9068-f14ebff6e9d6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6c40895d-3868-5e4d-9c14-11af6f96addf","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2b4b4c08-4cc0-5bd3-9897-e299762dfda5","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"6e86cad8-f6cd-50af-896f-644abaf1ced7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f0327d58-087f-55be-8c04-851ba71981ad","slug":"definition","fullItemName":"Definition"},{"id":"b417d8d4-23cc-5c70-9a7c-2862b1a0e8ae","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"4d6e6d92-ba5d-5270-bb5d-35cabd02f762","slug":"complications","fullItemName":"Complications"},{"id":"1a03c435-e5cd-51ef-8d07-3156e2c24840","slug":"prognosis","fullItemName":"Prognosis"},{"id":"bf28c805-c8fd-5214-92fd-164c8c8788a3","slug":"prevalence","fullItemName":"Prevalence"}]},{"id":"b00edd06-8e4f-525b-8ef7-c13a9dbb324e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b5eaeed0-7e4e-56af-b815-999ef927bdef","slug":"diagnosis-of-achilles-tendinopathy","fullItemName":"Diagnosis of Achilles tendinopathy"},{"id":"34cf88b7-c8ff-55e8-b38f-76df8ac1f7bf","slug":"diagnosis-of-achilles-tendon-rupture","fullItemName":"Diagnosis of Achilles tendon rupture"},{"id":"089a0bb5-68f6-5ca6-881f-02dd351d71a9","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"dc5e6af9-8b5e-504e-999a-6fc9e4f57296","fullItemName":"Management","slug":"management","subChapters":[{"id":"a1a83d59-c293-5bfb-a078-7091a0c52706","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"2079dd79-c9cf-5739-98f7-0758ec0adc7f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"e92d2ca0-f0dc-568e-a7c3-cef9cc1094a6","slug":"paracetamol-nsaids","fullItemName":"Paracetamol and NSAIDs"}]},{"id":"7520bb0c-3060-5fa4-bb93-b5925ee0047d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"fe9bcb65-fd1e-5e06-a874-69fb18de642b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"6372c076-6c9b-5d73-a748-8b8f82187ed4","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7e4fff6f-e0ff-5958-824d-2613bf441de4","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b6feb235-6eca-5423-9a56-7c39025cfccc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e5915315-219d-50d8-a14c-f43dbe0af10d","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4029ee68-9da4-5dbc-b713-2744f953300c","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9a1ea071-726f-5ade-89c0-37ac012f2f13","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"6e86cad8-f6cd-50af-896f-644abaf1ced7","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}